Commercial Information Circulars
24-hour hotline : 23 922 922
e-mail address : enquiry@tid.gov.hk
Ref. : EIC 631/2/5/1
30 November 2023
Dear Sirs,
Commercial Information Circular No. 856/2023
The Mainland of China : "Guidelines on the Compilation of Drug Package Inserts (Simplified Version) and Drug Package Inserts (Large Font Version)" and "Format Requirements for Digital Drug Package Inserts (Full Version)"
The Center for Drug Evaluation of the National Medical Products Administration issued on 24 November 2023 the "Guidelines on the Compilation of Drug Package Inserts (Simplified Version) and Drug Package Inserts (Large Font Version)" and the "Format Requirements for Digital Drug Package Inserts (Full Version)", which took effect on the date of promulgation. Please refer to the Appendix (pdf format) for the guidelines and requirements (available in Chinese only).
ENQUIRIES
2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.
Yours faithfully,
(Miss Sindy LEE)
for Director-General of Trade and Industry
Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.